Showing results (1-10 of 722) with videos related to
Sort By:
Pageof 73
Melanoma Management|September 8, 2018
Advances in immunotherapy for melanomaPaolo A Ascierto, James LarkinClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2014
Immuno-oncology combinations: a review of clinical experience and future prospectsScott J Antonia, James Larkin, Paolo A AsciertoMelanoma Research|October 2, 2015
Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?Reinhard Dummer, Dirk Schadendorf, Paolo A Ascierto, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2015
Immunotherapies and novel combinations: the focus of advances in the treatment of melanomaPaolo A AsciertoMelanoma Management|September 8, 2018
Combination approaches and anti-PD1 therapies: the focus of new research at ESMO and SMRPaolo A AsciertoTumori|February 8, 2014
Ipilimumab in the treatment of metastatic melanoma: a summary of recent studiesPaolo A AsciertoJournal of Immunotoxicology|April 25, 2012
Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1Ester Simeone, Paolo A AsciertoJournal for Immunotherapy of Cancer|December 1, 2022
Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinomaPaolo A Ascierto, Dirk SchadendorfOncoimmunology|September 20, 2018
Immunological effects of BRAF+MEK inhibitionPaolo A Ascierto, Reinhard DummerPageof 73